Literature DB >> 21063069

Family-based association analysis of the MAPT gene in Parkinson disease.

K S Wang1, J E Mullersman, X F Liu.   

Abstract

The MAPT gene has been shown to be associated with several neurodegenerative disorders, including forms of parkinsonism and Parkinson disease (PD), but the results reveal population differences. We investigated the association of 10 single-nucleotide polymorphisms (SNPs) in the region of MAPT on chromosome 17q21 with PD and age at onset, by using 443 discordant sib pairs in PD from a public dataset (Mayo-Perlegen LEAPS Collaboration). Association with PD was assessed by the FBAT using generalized estimating equations (FBAT-GEE), while the association with age at onset as a quantitative trait was evaluated using the FBAT-logrank statistic. Five SNPs were significantly associated with PD (P < 0.05) in an additive model, and 9 SNPs were associated with PD (P < 0.05) in dominant and recessive models. Interestingly, 8 PD-associated SNPs were also associated with age at onset of PD (P < 0.05) in dominant and recessive models. The SNP most significantly associated with PD and age at onset was rs17649641 (P = 0.015 and 0.021, respectively). Two-SNP haplotypes inferred from rs17563965 and rs17649641 also showed association with PD (P = 0.018) and age at onset (P = 0.026). These results provide further support for the role of MAPT in development of PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063069     DOI: 10.1007/BF03208881

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   2.653


  42 in total

Review 1.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Family-based association tests for survival and times-to-onset analysis.

Authors:  Christoph Lange; Deborah Blacker; Nan M Laird
Journal:  Stat Med       Date:  2004-01-30       Impact factor: 2.373

3.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

Review 4.  Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases.

Authors:  Athena Andreadis
Journal:  Biochim Biophys Acta       Date:  2005-01-03

5.  Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.

Authors:  E R Martin; W K Scott; M A Nance; R L Watts; J P Hubble; W C Koller; K Lyons; R Pahwa; M B Stern; A Colcher; B C Hiner; J Jankovic; W G Ondo; F H Allen; C G Goetz; G W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; R C Ribble; M W Booze; A Rogala; M A Hauser; F Zhang; R A Gibson; L T Middleton; A D Roses; J L Haines; B L Scott; M A Pericak-Vance; J M Vance
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

6.  Case-Control study of the extended tau gene haplotype in Parkinson's disease.

Authors:  D M Maraganore; D G Hernandez; A B Singleton; M J Farrer; S K McDonnell; M L Hutton; J A Hardy; W A Rocca
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

7.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.

Authors:  Wataru Satake; Yuko Nakabayashi; Ikuko Mizuta; Yushi Hirota; Chiyomi Ito; Michiaki Kubo; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Masahiko Watanabe; Atsushi Takeda; Hiroyuki Tomiyama; Kenji Nakashima; Kazuko Hasegawa; Fumiya Obata; Takeo Yoshikawa; Hideshi Kawakami; Saburo Sakoda; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Yusuke Nakamura; Tatsushi Toda
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

8.  PBAT: a comprehensive software package for genome-wide association analysis of complex family-based studies.

Authors:  Kristel Van Steen; Christoph Lange
Journal:  Hum Genomics       Date:  2005-03       Impact factor: 4.639

9.  Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Authors:  Nikolaos Refenes; Juliane Bolbrinker; Georgios Tagaris; Antonio Orlacchio; Nikolaos Drakoulis; Reinhold Kreutz
Journal:  BMC Neurol       Date:  2009-06-28       Impact factor: 2.474

10.  Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Authors:  An Goris; Caroline H Williams-Gray; Graeme R Clark; Thomas Foltynie; Simon J G Lewis; Joanne Brown; Maria Ban; Maria G Spillantini; Alastair Compston; David J Burn; Patrick F Chinnery; Roger A Barker; Stephen J Sawcer
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

View more
  4 in total

1.  Population biobanking in selected European countries and proposed model for a Polish national DNA bank.

Authors:  Jarosław Sak; Jakub Pawlikowski; Mariusz Goniewicz; Magdalena Witt
Journal:  J Appl Genet       Date:  2012-01-27       Impact factor: 3.240

2.  Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.

Authors:  Yaohua Yang; Lang Wu; Xiang Shu; Yingchang Lu; Xiao-Ou Shu; Qiuyin Cai; Alicia Beeghly-Fadiel; Bingshan Li; Fei Ye; Andrew Berchuck; Hoda Anton-Culver; Susana Banerjee; Javier Benitez; Line Bjørge; James D Brenton; Ralf Butzow; Ian G Campbell; Jenny Chang-Claude; Kexin Chen; Linda S Cook; Daniel W Cramer; Anna deFazio; Joe Dennis; Jennifer A Doherty; Thilo Dörk; Diana M Eccles; Digna Velez Edwards; Peter A Fasching; Renée T Fortner; Simon A Gayther; Graham G Giles; Rosalind M Glasspool; Ellen L Goode; Marc T Goodman; Jacek Gronwald; Holly R Harris; Florian Heitz; Michelle A Hildebrandt; Estrid Høgdall; Claus K Høgdall; David G Huntsman; Siddhartha P Kar; Beth Y Karlan; Linda E Kelemen; Lambertus A Kiemeney; Susanne K Kjaer; Anita Koushik; Diether Lambrechts; Nhu D Le; Douglas A Levine; Leon F Massuger; Keitaro Matsuo; Taymaa May; Iain A McNeish; Usha Menon; Francesmary Modugno; Alvaro N Monteiro; Patricia G Moorman; Kirsten B Moysich; Roberta B Ness; Heli Nevanlinna; Håkan Olsson; N Charlotte Onland-Moret; Sue K Park; James Paul; Celeste L Pearce; Tanja Pejovic; Catherine M Phelan; Malcolm C Pike; Susan J Ramus; Elio Riboli; Cristina Rodriguez-Antona; Isabelle Romieu; Dale P Sandler; Joellen M Schildkraut; Veronica W Setiawan; Kang Shan; Nadeem Siddiqui; Weiva Sieh; Meir J Stampfer; Rebecca Sutphen; Anthony J Swerdlow; Lukasz M Szafron; Soo Hwang Teo; Shelley S Tworoger; Jonathan P Tyrer; Penelope M Webb; Nicolas Wentzensen; Emily White; Walter C Willett; Alicja Wolk; Yin Ling Woo; Anna H Wu; Li Yan; Drakoulis Yannoukakos; Georgia Chenevix-Trench; Thomas A Sellers; Paul D P Pharoah; Wei Zheng; Jirong Long
Journal:  Cancer Res       Date:  2018-12-17       Impact factor: 13.312

Review 3.  Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

Authors:  Panchanan Maiti; Jayeeta Manna; Gary L Dunbar
Journal:  Transl Neurodegener       Date:  2017-10-25       Impact factor: 8.014

4.  Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes.

Authors:  Irene Lobon; Manuel Solís-Moruno; David Juan; Ashraf Muhaisen; Federico Abascal; Paula Esteller-Cucala; Raquel García-Pérez; Maria Josep Martí; Eduardo Tolosa; Jesús Ávila; Raheleh Rahbari; Tomas Marques-Bonet; Ferran Casals; Eduardo Soriano
Journal:  Front Aging       Date:  2022-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.